Global Psoriasis Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 11, 2020  |  224 PAGES  |  REPORT CODE: CMM344032
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin.

The Psoriasis Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period. The research provides insights for the global Psoriasis Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Psoriasis Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Psoriasis Drug Market Segmentations:

By Players:

  • AbbVie

  • Johnson & Johnson

  • Bayer

  • Galderma

  • Bristol-Myers Squibb

  • Novartis

  • Pfizer

  • Merz Pharma

  • Valeant

  • LEO Pharma

  • GlaxoSmithKline

By Types:

  • External Use

  • Oral

  • Injection

By End-User:

  • Hospital

  • Drugs Store

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Psoriasis Drug Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Psoriasis Drug Market Size and Growth Rate of External Use from 2014 to 2026

    • 1.3.2 Global Psoriasis Drug Market Size and Growth Rate of Oral from 2014 to 2026

    • 1.3.3 Global Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Psoriasis Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Global Psoriasis Drug Market Size and Growth Rate of Drugs Store from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Psoriasis Drug Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Psoriasis Drug Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Psoriasis Drug by Major Types

    • 3.4.1 Psoriasis Drug Market Size and Growth Rate of External Use

    • 3.4.2 Psoriasis Drug Market Size and Growth Rate of Oral

    • 3.4.3 Psoriasis Drug Market Size and Growth Rate of Injection

4 Segmentation of Psoriasis Drug Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Psoriasis Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Psoriasis Drug in Hospital

    • 4.4.2 Market Size and Growth Rate of Psoriasis Drug in Drugs Store

5 Market Analysis by Major Regions

  • 5.1 Global Psoriasis Drug Production Analysis by Major Regions

  • 5.2 Global Psoriasis Drug Consumption Analysis by Major Regions

  • 5.3 Global Psoriasis Drug Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Psoriasis Drug Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Psoriasis Drug Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Psoriasis Drug Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Psoriasis Drug Production, Import, Consumption and Export Analysis

6 Product Commodity of Psoriasis Drug Market in Major Countries

  • 6.1 Top 5 Export Countries in Psoriasis Drug market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Psoriasis Drug market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Psoriasis Drug market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Psoriasis Drug market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Psoriasis Drug market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Psoriasis Drug market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Psoriasis Drug Landscape Analysis

  • 7.1 North America Psoriasis Drug Landscape Analysis by Major Types

  • 7.2 North America Psoriasis Drug Landscape Analysis by Major End-Users

  • 7.3 North America Psoriasis Drug Landscape Analysis by Major Countries

    • 7.3.1 United States Psoriasis Drug Market Volume and Growth Rate

    • 7.3.2 Canada Psoriasis Drug Market Volume and Growth Rate

    • 7.3.3 Mexico Psoriasis Drug Market Volume and Growth Rate

8 Europe Psoriasis Drug Landscape Analysis

  • 8.1 Europe Psoriasis Drug Landscape Analysis by Major Types

  • 8.2 Europe Psoriasis Drug Landscape Analysis by Major End-Users

  • 8.3 Europe Psoriasis Drug Landscape Analysis by Major Countries

    • 8.3.1 Germany Psoriasis Drug Market Volume and Growth Rate

    • 8.3.2 UK Psoriasis Drug Market Volume and Growth Rate

    • 8.3.3 France Psoriasis Drug Market Volume and Growth Rate

    • 8.3.4 Italy Psoriasis Drug Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Psoriasis Drug Market Volume and Growth Rate

    • 8.3.6 Spain Psoriasis Drug Market Volume and Growth Rate

    • 8.3.7 Belgium Psoriasis Drug Market Volume and Growth Rate

    • 8.3.8 Poland Psoriasis Drug Market Volume and Growth Rate

    • 8.3.9 Russia Psoriasis Drug Market Volume and Growth Rate

    • 8.3.10 Turkey Psoriasis Drug Market Volume and Growth Rate

9 Asia Pacific Psoriasis Drug Landscape Analysis

  • 9.1 Asia Pacific Psoriasis Drug Landscape Analysis by Major Types

  • 9.2 Asia Pacific Psoriasis Drug Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Psoriasis Drug Landscape Analysis by Major Countries

    • 9.3.1 China Psoriasis Drug Market Volume and Growth Rate

    • 9.3.2 Japan Psoriasis Drug Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Psoriasis Drug Market Volume and Growth Rate

    • 9.3.4 India Psoriasis Drug Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Psoriasis Drug Market Volume and Growth Rate

    • 9.3.6 South Korea Psoriasis Drug Market Volume and Growth Rate

10 Latin America, Middle East & Africa Psoriasis Drug Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Psoriasis Drug Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Psoriasis Drug Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Psoriasis Drug Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Psoriasis Drug Market Volume and Growth Rate

    • 10.3.2 Brazil Psoriasis Drug Market Volume and Growth Rate

    • 10.3.3 Nigeria Psoriasis Drug Market Volume and Growth Rate

    • 10.3.4 South Africa Psoriasis Drug Market Volume and Growth Rate 

    • 10.3.5 Argentina Psoriasis Drug Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 AbbVie

    • 11.1.1 AbbVie Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Johnson & Johnson

    • 11.2.1 Johnson & Johnson Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Bayer

    • 11.3.1 Bayer Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Galderma

    • 11.4.1 Galderma Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Bristol-Myers Squibb

    • 11.5.1 Bristol-Myers Squibb Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Novartis

    • 11.6.1 Novartis Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Pfizer

    • 11.7.1 Pfizer Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Merz Pharma

    • 11.8.1 Merz Pharma Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Valeant

    • 11.9.1 Valeant Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 LEO Pharma

    • 11.10.1 LEO Pharma Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 GlaxoSmithKline

    • 11.11.1 GlaxoSmithKline Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 110 Figures and 167 Tables)

  • Figure Product Picture

  • Figure Psoriasis Drug Market Size and Growth Rate of External Use from 2014 to 2026

  • Figure Psoriasis Drug Market Size and Growth Rate of Oral from 2014 to 2026

  • Figure Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Psoriasis Drug Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Psoriasis Drug Market Size and Growth Rate of Drugs Store from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Psoriasis Drug Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Psoriasis Drug

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Psoriasis Drug by Different Types from 2014 to 2026

  • Table Consumption Share of Psoriasis Drug by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of External Use

  • Figure Market Size and Growth Rate of Oral

  • Figure Market Size and Growth Rate of Injection

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Psoriasis Drug by Different End-Users from 2014 to 2026

  • Table Consumption Share of Psoriasis Drug by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Drugs Store

  • Table Global Psoriasis Drug Production by Major Regions

  • Table Global Psoriasis Drug Production Share by Major Regions

  • Figure Global Psoriasis Drug Production Share by Major Regions in 2014

  • Figure Global Psoriasis Drug Production Share by Major Regions in 2018

  • Figure Global Psoriasis Drug Production Share by Major Regions in 2026

  • Table Global Psoriasis Drug Consumption by Major Regions

  • Table Global Psoriasis Drug Consumption Share by Major Regions

  • Figure Global Psoriasis Drug Consumption Share by Major Regions in 2014

  • Figure Global Psoriasis Drug Consumption Share by Major Regions in 2018

  • Figure Global Psoriasis Drug Consumption Share by Major Regions in 2026

  • Table North America Psoriasis Drug Production, Import, Consumption and Export Analysis

  • Table Europe Psoriasis Drug Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Psoriasis Drug Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Psoriasis Drug Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Psoriasis Drug market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Psoriasis Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Psoriasis Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Psoriasis Drug market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Psoriasis Drug Consumption by Types from 2014 to 2026

  • Table North America Psoriasis Drug Consumption Share by Types from 2014 to 2026

  • Figure North America Psoriasis Drug Consumption Share by Types in 2014

  • Figure North America Psoriasis Drug Consumption Share by Types in 2018

  • Figure North America Psoriasis Drug Consumption Share by Types in 2026

  • Table North America Psoriasis Drug Consumption by End-Users from 2014 to 2026

  • Table North America Psoriasis Drug Consumption Share by End-Users from 2014 to 2026

  • Figure North America Psoriasis Drug Consumption Share by End-Users in 2014

  • Figure North America Psoriasis Drug Consumption Share by End-Users in 2018

  • Figure North America Psoriasis Drug Consumption Share by End-Users in 2026

  • Table North America Psoriasis Drug Consumption by Major Countries from 2014 to 2026

  • Table North America Psoriasis Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Psoriasis Drug Consumption Share by Major Countries in 2014

  • Figure North America Psoriasis Drug Consumption Share by Major Countries in 2018

  • Figure North America Psoriasis Drug Consumption Share by Major Countries in 2026

  • Figure United States Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Psoriasis Drug Consumption by Types from 2014 to 2026

  • Table Europe Psoriasis Drug Consumption Share by Types from 2014 to 2026

  • Figure Europe Psoriasis Drug Consumption Share by Types in 2014

  • Figure Europe Psoriasis Drug Consumption Share by Types in 2018

  • Figure Europe Psoriasis Drug Consumption Share by Types in 2026

  • Table Europe Psoriasis Drug Consumption by End-Users from 2014 to 2026

  • Table Europe Psoriasis Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Psoriasis Drug Consumption Share by End-Users in 2014

  • Figure Europe Psoriasis Drug Consumption Share by End-Users in 2018

  • Figure Europe Psoriasis Drug Consumption Share by End-Users in 2026

  • Table Europe Psoriasis Drug Consumption by Major Countries from 2014 to 2026

  • Table Europe Psoriasis Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Psoriasis Drug Consumption Share by Major Countries in 2014

  • Figure Europe Psoriasis Drug Consumption Share by Major Countries in 2018

  • Figure Europe Psoriasis Drug Consumption Share by Major Countries in 2026

  • Figure Germany Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure France Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Psoriasis Drug Consumption by Types from 2014 to 2026

  • Table Asia Pacific Psoriasis Drug Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Psoriasis Drug Consumption Share by Types in 2014

  • Figure Asia Pacific Psoriasis Drug Consumption Share by Types in 2018

  • Figure Asia Pacific Psoriasis Drug Consumption Share by Types in 2026

  • Table Asia Pacific Psoriasis Drug Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Psoriasis Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Psoriasis Drug Consumption Share by End-Users in 2014

  • Figure Asia Pacific Psoriasis Drug Consumption Share by End-Users in 2018

  • Figure Asia Pacific Psoriasis Drug Consumption Share by End-Users in 2026

  • Table Asia Pacific Psoriasis Drug Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Psoriasis Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Psoriasis Drug Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Psoriasis Drug Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Psoriasis Drug Consumption Share by Major Countries in 2026

  • Figure China Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandPsoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure India Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Psoriasis Drug Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Psoriasis Drug Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Psoriasis Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Psoriasis Drug Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Psoriasis Drug Consumption Share by Major Countries in 2026

  • Figure GCC Countries Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Psoriasis Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of AbbVie

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

  • Figure Sales and Growth Rate Analysis of AbbVie

  • Figure Revenue and Market Share Analysis of AbbVie

  • Table Product and Service Introduction of AbbVie

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of Bayer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

  • Figure Sales and Growth Rate Analysis of Bayer

  • Figure Revenue and Market Share Analysis of Bayer

  • Table Product and Service Introduction of Bayer

  • Table Company Profile and Development Status of Galderma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma

  • Figure Sales and Growth Rate Analysis of Galderma

  • Figure Revenue and Market Share Analysis of Galderma

  • Table Product and Service Introduction of Galderma

  • Table Company Profile and Development Status of Bristol-Myers Squibb

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

  • Table Product and Service Introduction of Bristol-Myers Squibb

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Merz Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma

  • Figure Sales and Growth Rate Analysis of Merz Pharma

  • Figure Revenue and Market Share Analysis of Merz Pharma

  • Table Product and Service Introduction of Merz Pharma

  • Table Company Profile and Development Status of Valeant

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant

  • Figure Sales and Growth Rate Analysis of Valeant

  • Figure Revenue and Market Share Analysis of Valeant

  • Table Product and Service Introduction of Valeant

  • Table Company Profile and Development Status of LEO Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LEO Pharma

  • Figure Sales and Growth Rate Analysis of LEO Pharma

  • Figure Revenue and Market Share Analysis of LEO Pharma

  • Table Product and Service Introduction of LEO Pharma

  • Table Company Profile and Development Status of GlaxoSmithKline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline

  • Table Product and Service Introduction of GlaxoSmithKline


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top